The effects of a single evening dose of 3 mg eszopiclone on next day driving ability and psychomotor/memory function in healthy volunteers compared to placebo.

Trial Profile

The effects of a single evening dose of 3 mg eszopiclone on next day driving ability and psychomotor/memory function in healthy volunteers compared to placebo.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2012

At a glance

  • Drugs Eszopiclone (Primary)
  • Indications Insomnia
  • Focus Pharmacodynamics
  • Sponsors Sunovion Pharmaceuticals
  • Most Recent Events

    • 14 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top